Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

Historical Holders from Q2 2017 to Q3 2025

Symbol
OVID on Nasdaq
CUSIP
690469101
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
72.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
36.2M
Holdings value
$47.1M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
80
Number of buys
42
Number of sells
-36
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Madison Avenue Partners, LP 4% $890K 2.85M Madison Avenue Partners, LP Dec 31, 2024
BlackRock, Inc. 1.9% $397K 1.37M BlackRock, Inc. Jun 30, 2025
Rubric Capital Management LP 0.67% $139K 479K Rubric Capital Management LP Jun 30, 2025

Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 36.2M $47.1M +$6.61M $1.30 80
2025 Q2 36M $11.9M -$3.39M $0.33 69
2025 Q1 46.4M $14.5M -$2.82M $0.31 81
2024 Q4 47.6M $44.4M +$934K $0.93 80
2024 Q3 46.3M $54.7M -$2.31M $1.18 76
2024 Q2 38.5M $29.6M -$20.9M $0.77 72
2024 Q1 50.1M $153M -$4.52M $3.05 80
2023 Q4 7.56M $24.3M -$57.6K $3.22 2
2023 Q3 42.3M $163M +$5.68M $3.84 64
2023 Q2 41M $135M +$8.71M $3.28 69
2023 Q1 38.7M $99.8M +$650K $2.58 60
2022 Q4 38.6M $71.7M +$2.58M $1.86 56
2022 Q3 33.9M $62.3M +$1.74M $1.84 50
2022 Q2 34.2M $73.5M -$3M $2.15 51
2022 Q1 35.1M $110M +$3.43M $3.14 60
2021 Q4 34M $109M +$1.31M $3.21 63
2021 Q3 33.6M $113M +$499K $3.36 70
2021 Q2 33.2M $130M -$11.5M $3.91 77
2021 Q1 32.8M $132M +$41M $4.02 84
2020 Q4 24.8M $57.4M -$5.6M $2.31 73
2020 Q3 25.1M $144M +$11.2M $5.74 90
2020 Q2 19.7M $145M +$45.8M $7.37 76
2020 Q1 13.6M $40.5M -$7.1M $2.98 52
2019 Q4 17.7M $73.6M +$38.2M $4.15 57
2019 Q3 8.21M $26.6M -$5.12M $3.24 37
2019 Q2 10.1M $18.7M -$3.46M $1.85 32
2019 Q1 12.3M $21.7M +$9.09M $1.77 46
2018 Q4 6.84M $16.5M -$8.55M $2.42 46
2018 Q3 7.39M $41.9M -$3.04M $5.67 47
2018 Q2 7.65M $59.7M -$351K $7.80 45
2018 Q1 7.05M $49.8M -$9.28M $7.07 48
2017 Q4 7.82M $77.2M +$5.97M $9.87 48
2017 Q3 7.22M $61.5M -$6.77M $8.57 42
2017 Q2 7.96M $81.5M +$81.5M $10.49 42